A secreted Cryptosporidium parvum dipeptidyl peptidase (CpDPP1) is targetable for developing cryptosporidial therapeutics
Authors:
- Peng JiangPJPeng Jiang
- Jigang YinJYJigang Yin
- Tao ChenTCTao Chen
- Bingjie XuBXBingjie Xu
- Congying KouCKCongying Kou
- Guan ZhuGuan Zhu
- Dongqiang WangDWDongqiang Wang
Open Access
- 23 October 2026
- journal article
- Published by Elsevier in International Journal for Parasitology: Drugs and Drug Resistance
- Vol. 32
Abstract
No abstract availableFunding Information
- National Natural Science Foundation of China
This publication has 36 references indexed in Scilit:
- Cryptosporidium Oocyst Purification Using Discontinuous Gradient Centrifugation2025
- Phenotypic High-Throughput Screening and Drug Efficacy Test Against the Growth of Cryptosporidium parvum In Vitro by qRT-PCR2025
- Hypocrellin A exerts antitumor effects by inhibiting the FGFR1 signaling pathway in non-small cell lung cancerPhytomedicine, 2022
- Cryptosporidium rhoptry effector protein ROP1 injected during invasion targets the host cytoskeletal modulator LMO7Cell Host & Microbe, 2021
- High-Throughput Screening of Drugs Against the Growth of Cryptosporidium parvum In Vitro by qRT-PCR2019
- A Genetically Tractable, Natural Mouse Model of Cryptosporidiosis Offers Insights into Host Protective ImmunityCell Host & Microbe, 2019
- Treatment of Cryptosporidium: What We Know, Gaps, and the Way ForwardCurrent Tropical Medicine Reports, 2015
- Burden and aetiology of diarrhoeal disease in infants and young children in developing countries (the Global Enteric Multicenter Study, GEMS): a prospective, case-control studyThe Lancet, 2013
- Biochemical characterization of Plasmodium falciparum dipeptidyl aminopeptidase 1Molecular and Biochemical Parasitology, 2011
- Affinity Purification of Autoantibodies from an Antigen Strip Excised from a Nitrocellulose Protein Blot2009